Sign in / Register 
Mouse Anti-Monkey IgG-AP (SB108a)
Cat. No.:
4700-04
AP Anti-Monkey IgG for use in ELISA and western blot assays.
$231.00
| Clone | SB108a |
|---|---|
| Isotype | Mouse (BALB/c) IgG1κ |
| Isotype Control | Mouse IgG1-AP (15H6) |
| Specificity | Rhesus and cynomolgus IgG Minimal reactivity to human and rabbit immunoglobulins, goat IgG, and mouse, rat, hamster, guinea pig, sheep, donkey, bovine, horse, porcine, feline, and chicken serum |
| Immunogen | Rhesus IgG |
| Conjugate | AP (Alkaline Phosphatase) |
| Buffer Formulation | 50 mM Tris/1 mM MgCl2/50% Glycerol containing < 0.1% sodium azide, pH 8.0 |
| Clonality | Monoclonal |
| Concentration | Lot specific |
| Volume | 1.0 mL |
| Recommended Storage | 2-8°C |
| Applications | ELISA – Quality tested 1-8 FLISA – Quality tested Flow Cytometry – Reported in literature 9 Western Blot – Reported in literature 10 |
| RRID Number | AB_2796068 |
Documentation
Certificate of Analysis Lookup
Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view
- 1. Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature. 2011;470:543-7. (ELISA)
- 2. Wang J, Tricoche N, Du L, Hunter M, Zhan B, Goud G, et al. The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates. PLoS One. 2012;7(5):e37019. (ELISA)
- 3. Ferraro B, Talbott KT, Balakrishnan A, Cisper N, Morrow MP, Hutnick NA, et al. Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. Infect Immun. 2013;81:3709-20. (ELISA)
- 4. Padte NN, Boente-Carrera M, Andrews CD, McManus J, Grasperge BF, Gettie A, et al. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. PLoS One. 2013;8(10):e78407. (ELISA)
- 5. Sholukh AM, Watkins JD, Vyas HK, Gupta S, Lakhashe SK, Thorat S, et al. Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge. Vaccine. 2015;33:2086-95. (ELISA)
- 6. Bolton DL, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human immunodeficiency virus type 1 monoclonal antibodies suppress acute simian-human immunodeficiency virus viremia and limit seeding of cell-associated viral reservoirs. J Virol. 2015;90:1321-32. (ELISA)
- 7. Yang Z, Wang H, Salcedo TW, Suchard SJ, Xie JH, Schneeweis LA, et al. Integrated pharmacokinetic/pharmacodynamic analysis for determining the minimal anticipated biological effect level of a novel anti-CD28 receptor antagonist BMS-931699. J Pharmacol Exp Ther. 2015;355:506-15. (ELISA)
- 8. Kutzler MA, Wise MC, Hutnick NA, Moldoveanu Z, Hunter M, Reuter MA, et al. Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge. Mucosal Immunol. 2016;9:13-23. (ELISA)
- 9. Guo J, Zuo T, Cheng L, Wu X, Tang J, Sun C, et al. Simian immunodeficiency virus infection evades vaccine-elicited antibody responses to V2 region. J Acquir Immune Defic Syndr. 2015;68:502-10. (FC)
- 10. Parks CL, Koff WC, inventors; International AIDS Vaccine Initiative, assignee. Transgenic Vero-CD4-CCR5 cell line. United States patent applicaton publication US 2017/0266272 A1. 2017 Sep21. (WB)
See All References
Related Products
Check items to add to the cart or
